In particular, gene amplification and/or overexpression of CCND1 have been associated with poor prognosis and reduced overall survival in CC patients whereas BCL2L1 has been shown to play a role in the adenoma-to-carcinoma progression [58, 59]. The gene discussed is BCL2L1; the disease is carcinoma.